Taysha Gene Price To Sales vs. Number Of Shares Shorted
| TSHA Stock | USD 2.52 0.04 1.56% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0048 | 0.0054 |
|
|
For Taysha Gene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Taysha Gene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Taysha Gene Therapies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Taysha Gene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Taysha Gene Therapies over time as well as its relative position and ranking within its peers.
Taysha |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taysha Gene. If investors know Taysha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taysha Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.63 | Revenue Per Share 0.042 | Quarterly Revenue Growth (0.62) | Return On Assets (0.27) | Return On Equity (1.15) |
The market value of Taysha Gene Therapies is measured differently than its book value, which is the value of Taysha that is recorded on the company's balance sheet. Investors also form their own opinion of Taysha Gene's value that differs from its market value or its book value, called intrinsic value, which is Taysha Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taysha Gene's market value can be influenced by many factors that don't directly affect Taysha Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taysha Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taysha Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taysha Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Taysha Gene Therapies Number Of Shares Shorted vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Taysha Gene's current stock value. Our valuation model uses many indicators to compare Taysha Gene value to that of its competitors to determine the firm's financial worth. Taysha Gene Therapies is rated third in price to sales category among its peers. It is rated second in number of shares shorted category among its peers making about 311,977 of Number Of Shares Shorted per Price To Sales. At present, Taysha Gene's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taysha Gene's earnings, one of the primary drivers of an investment's value.Taysha Number Of Shares Shorted vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Taysha Gene |
| = | 50.23 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Taysha Gene |
| = | 15.67 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Taysha Number Of Shares Shorted Comparison
Taysha Gene is currently under evaluation in number of shares shorted category among its peers.
Taysha Gene Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Taysha Gene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Taysha Gene will eventually generate negative long term returns. The profitability progress is the general direction of Taysha Gene's change in net profit over the period of time. It can combine multiple indicators of Taysha Gene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -72.4 M | -76.1 M | |
| Income Before Tax | -111.6 M | -117.1 M | |
| Net Loss | -157.1 M | -149.2 M | |
| Net Loss | -111.6 M | -117.1 M | |
| Income Tax Expense | 1.2 M | 1.3 M | |
| Net Interest Income | -3.7 M | -3.6 M | |
| Interest Income | 1.9 M | 1.9 M | |
| Net Loss | -214.4 M | -225.1 M | |
| Non Operating Income Net Other | -15.3 M | -16.1 M | |
| Total Other Income Expense Net | -39.1 M | -37.2 M | |
| Change To Netincome | 66.6 M | 70 M | |
| Net Loss | (0.96) | (1.01) | |
| Income Quality | 0.65 | 0.38 | |
| Net Income Per E B T | 0.92 | 0.73 |
Taysha Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Taysha Gene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Taysha Gene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Taysha Gene's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Taysha Gene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Use Investing Themes to Complement your Taysha Gene position
In addition to having Taysha Gene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cigarettes Thematic Idea Now
Cigarettes
Tobacco makers and distributors across globe. The Cigarettes theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
To fully project Taysha Gene's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Taysha Gene Therapies at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Taysha Gene's income statement, its balance sheet, and the statement of cash flows.